...
机译:针对光动力疗法的新策略。光动力剂酞菁锌与小分子靶标抗癌药厄洛替尼的分子组合
College of Chemistry and Chemical Engineering, Fuzhou University, Fuzhou, 350108, P. R. China;
College of Chemistry and Chemical Engineering, Fuzhou University, Fuzhou, 350108, P. R. China;
College of Chemistry and Chemical Engineering, Fuzhou University, Fuzhou, 350108, P. R. China;
College of Chemistry and Chemical Engineering, Fuzhou University, Fuzhou, 350108, P. R. China;
College of Chemistry and Chemical Engineering, Fuzhou University, Fuzhou, 350108, P. R. China;
College of Chemistry and Chemical Engineering, Fuzhou University, Fuzhou, 350108, P. R. China;
机译:厄洛替尼类似物取代的锌(Ⅱ)酞菁类药物用于小分子靶标光动力癌症的治疗
机译:基于分子目标的抗癌光敏剂:厄洛替尼-锌(II)酞菁偶联物的合成和体外光动力活性
机译:光动力治疗剂酞菁硅和抗癌药顺铂的分子组合
机译:游离酞菁和酞菁金纳米粒子的光毒性作用对黑色素瘤癌症的靶向光动力治疗
机译:新型硅(IV)酞菁类作为针对光动力疗法的Efficeint光敏剂。
机译:改进的光动力抗癌活性和有前途锌(II)酞菁 - 喹啉缀合物光敏剂的机制
机译:用于光动力疗法的新型不对称锌(II)酞菁的合成。